Strategies for managing cytomegalovirus in transplant recipients
RR Razonable - Expert opinion on pharmacotherapy, 2010 - Taylor & Francis
Importance of the field: Cytomegalovirus (CMV) is the most important pathogen that affects
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …
Strategies for managing cytomegalovirus in transplant recipients
RR Razonable - Expert Opinion on Pharmacotherapy, 2010 - mayoclinic.elsevierpure.com
Importance of the field: Cytomegalovirus (CMV) is the most important pathogen that affects
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …
Strategies for managing cytomegalovirus in transplant recipients
RR Razonable - Expert opinion on pharmacotherapy, 2010 - pubmed.ncbi.nlm.nih.gov
Importance of the field Cytomegalovirus (CMV) is the most important pathogen that affects
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …
[引用][C] Strategies for managing cytomegalovirus in transplant recipients
RR Razonable - Expert Opinion on Pharmacotherapy, 2010 - cir.nii.ac.jp
[引用][C] Strategies for managing cytomegalovirus in transplant recipients.
RR Razonable - Expert Opinion on Pharmacotherapy, 2010 - europepmc.org
This review provides a brief overview of the direct and indirect effects of CMV disease and
the traditional and newly described factors that increase the risk of disease after …
the traditional and newly described factors that increase the risk of disease after …